16 research outputs found
Prospects for gulf of Mexico environmental recovery and restoration
Previous oil spills provide clear evidence that ecosystem restoration efforts are challenging, and recovery can take decades. Similar to the Ixtoc 1 well blowout in 1979, the Deepwater Horizon (DWH) oil spill was enormous both in volume of oil spilled and duration, resulting in environmental impacts from the deep ocean to the Gulf of Mexico coastline. Data collected during the National Resource Damage Assessment showed significant damage to coastal areas (especially marshes), marine organisms, and deep-sea habitat. Previous spills have shown that disparate regions recover at different rates, with especially long-term effects in salt marshes and deepsea habitat. Environmental recovery and restoration in the northern Gulf of Mexico are dependent upon fundamental knowledge of ecosystem processes in the region. PostDWH research data provide a starting point for better understanding baselines and ecosystem processes. It is imperative to use the best science available to fully understand DWH environmental impacts and determine the appropriate means to ameliorate those impacts through restoration. Filling data gaps will be necessary to make better restoration decisions, and establishing new baselines will require long-term studies. Future research, especially via NOAA’s RESTORE Science Program and the state-based Centers of Excellence, should provide a path to understanding the potential for restoration and recovery of this vital marine ecosystem
The Public Repository of Xenografts enables discovery and randomized phase II-like trials in mice
More than 90% of drugs with preclinical activity fail in human trials, largely due to insufficient efficacy. We hypothesized that adequately powered trials of patient-derived xenografts (PDX) in mice could efficiently define therapeutic activity across heterogeneous tumors. To address this hypothesis, we established a large, publicly available repository of well-characterized leukemia and lymphoma PDXs that undergo orthotopic engraftment, called the Public Repository of Xenografts (PRoXe). PRoXe includes all de-identified information relevant to the primary specimens and the PDXs derived from them. Using this repository, we demonstrate that large studies of acute leukemia PDXs that mimic human randomized clinical trials can characterize drug efficacy and generate transcriptional, functional, and proteomic biomarkers in both treatment-naive and relapsed/refractory disease